Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan

Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan

Background/AimsAnti-tumor necrosis factor drugs (anti-TNF) and thiopurines are important treatment options in patients with inflammatory bowel disease (IBD), including during pregnancy. However, there are limited data on the benefit/risk profile of anti-TNF and thiopurines during pregnancy in Asia....

Full description

Bibliographic Details
Main Authors: Shunsuke Komoto, Satoshi Motoya, Yuji Nishiwaki, Toshiyuki Matsui, Reiko Kunisaki, Katsuyoshi Matsuoka, Naoki Yoshimura, Takashi Kagaya, Makoto Naganuma, Nobuyuki Hida, Mamoru Watanabe, Toshifumi Hibi, Yasuo Suzuki, Soichiro Miura, Ryota Hokari
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2016-04-01
Series:Intestinal Research
Subjects:
Inflammatory bowel diseases
Anti tumor necrosis factor-alpha
Thiopurines
Pregnancy outcome
Online Access:http://www.irjournal.org/upload/pdf/ir-14-139.pdf

Internet

http://www.irjournal.org/upload/pdf/ir-14-139.pdf

Similar Items